TWN SERIES ON INTELLECTUAL PROPERTY AND COVID-19 VACCINES

• IP & COVID-19 Vaccines Series #4: Pandemic profiteers?: Publicly funded Vanderbilt University aims to make the COVID-19 disaster its financial windfall
  by Edward Hammond (August 2020)

• IP & COVID-19 Vaccines Series #3: Patent dispute looms as a major complication for Moderna’s COVID-19 vaccine
  by Edward Hammond (August 2020)

• IP & COVID-19 Vaccines Series #2: Pandemic intellectual property dispute deepens as Inovio is countersued, leaving its COVID-19 candidate in limbo
  by Edward Hammond (July 2020)

• IP & COVID-19 Vaccines Series #1: Lawsuit holds back production of CEPI/Gates Foundation funded vaccine candidate
  by Edward Hammond (June 2020)